Newsroom

Featured

Featured

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue

story

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue

Published by Airfinity

Sep 16, 2022

How nasal-spray vaccines could change the pandemic

press

How nasal-spray vaccines could change the pandemic

Published by Nature

Sep 6, 2022

Airfinity estimates a shortage of up to 55 million monkeypox vaccine doses

press

Airfinity estimates a shortage of up to 55 million monkeypox vaccine doses

Published by Cinco Días

Aug 29, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

story

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Published by Airfinity

Aug 25, 2022

Global Supply and Demand: The future of the antivirals landscape

webinar

Global Supply and Demand: The future of the antivirals landscape

Published by Airfinity

Jun 16, 2022

play button
AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

story

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Published by Airfinity

Jul 13, 2022

Long-COVID treatments: why the world is still waiting

press

Long-COVID treatments: why the world is still waiting

Published by Nature

Aug 9, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

story

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Published by Airfinity

Jul 25, 2022

Airfinity appoints its first ever Chief Product Officer, Colin Willians

story

Airfinity appoints its first ever Chief Product Officer, Colin Willians

Published by Airfinity

Jul 4, 2022